Humana Inc Intrinsic Stock Value – Hexagon Capital Partners LLC Sells Shares of Humana in 2023
March 26, 2023
Trending News ☀️
In 2023, the Hexagon Capital Partners LLC completed the sale of its shares in Humana Inc ($NYSE:HUM). This announcement came as a surprise to many investors, as the company had been a long-term investor in this healthcare giant. Humana Inc. is a leading healthcare provider that offers a wide range of services and products, from managed care services to Medicare and Medicaid. It provides private and public health care coverage to millions of people throughout the country and is a major provider of Medicare and Medicaid services. Through its many initiatives, Humana Inc. has become a leader in providing quality, affordable care to its customers.
The disposal of their shares by Hexagon Capital Partners LLC was seen by many as a sign that the company was looking to move away from its traditional focus on healthcare and move into more of an investment-focused business model. While the company has not yet stated any specific plans for the funds generated from the sale of their shares, it is likely that these funds will be used for other investments or reinvested back into healthcare-related activities. Although Humana Inc. has lost one of its largest investors, it will no doubt continue to be an important player in the healthcare industry. With this sale, Hexagon Capital Partners LLC has made a significant contribution to the healthcare industry and will no doubt continue to make investments in other sectors.
Market Price
On Friday, Hexagon Capital Partners LLC sold shares of Humana Inc. in the 2023 fiscal year. Market sentiment around the stock was overwhelmingly positive at the time of the sale. Humana Inc’s stock opened at $491.9 and closed at $502.4, representing a 2.3% increase from the previous closing price of $491.4. This indicates that investors continue to be optimistic about Humana Inc’s performance in the coming year. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Humana Inc. More…
Total Revenues | Net Income | Net Margin |
92.87k | 2.81k | 2.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Humana Inc. More…
Operations | Investing | Financing |
4.59k | -1.01k | -1.91k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Humana Inc. More…
Total Assets | Total Liabilities | Book Value Per Share |
43.05k | 27.68k | 128.39 |
Key Ratios Snapshot
Some of the financial key ratios for Humana Inc are shown below. More…
3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
12.7% | – | 4.3% |
FCF Margin | ROE | ROA |
3.7% | 15.7% | 5.8% |
Analysis – Humana Inc Intrinsic Stock Value
At GoodWhale, we have conducted an analysis of HUMANA INC‘s wellbeing and our proprietary Valuation Line has calculated the fair value of their share to be around $504.3. We believe that HUMANA INC is a good investment option for people looking to gain good returns. More…
Peers
In the ever-changing world of healthcare, Humana Inc. has been a leader in providing quality services to its customers. However, the company faces stiff competition from the likes of UnitedHealth Group Inc, Cigna Corp, and Oscar Health Inc. All of these companies are striving to provide the best possible healthcare experience to their customers.
– UnitedHealth Group Inc ($NYSE:UNH)
UnitedHealth Group Inc. is an American for-profit managed health care company based in Minnetonka, Minnesota. It is the largest healthcare company in the world by revenue, with 2019 revenue of $242.2 billion. The company offers health care products and services through two operating businesses: UnitedHealthcare and Optum.
UnitedHealthcare provides health benefits and services to individuals, families, and businesses through a wide array of plans and programs, including health insurance, pharmacy benefits, vision, dental, and other supplemental health and wellness benefits. Optum is a health services and innovation company that provides technology-enabled health services and software. It offers healthcare information technology, data analytics, and research and consulting services to the healthcare industry.
The company has a market capitalization of $488.16 billion as of April 2021 and a return on equity of 21.75%.
– Cigna Corp ($NYSE:CI)
Cigna Corp is a health services company with a market cap of 88.46 billion as of 2022. The company has a return on equity of 11.01%. Cigna Corp provides medical, dental, disability, life, and other health insurance products and services. The company also offers pharmacy benefit management services.
– Oscar Health Inc ($NYSE:OSCR)
Oscar Health is a technology-driven health insurance company founded in 2012. The company’s mission is to make health insurance simple, transparent, and human.
Oscar uses technology to simplify the health insurance experience for consumers and providers. The company has a suite of tools that helps consumers understand their benefits, find doctors, and estimate the cost of care. For providers, Oscar offers a platform that streamlines claims processing and provides real-time insights into patients’ health insurance benefits.
Oscar Health is headquartered in New York City and is available in nine states: California, Colorado, Florida, Georgia, Illinois, Michigan, New Jersey, New York, and Texas.
Summary
Humana Inc. is a healthcare services and insurance provider that provides a variety of plans and solutions to customers. Recently, Hexagon Capital Partners LLC sold a portion of their shares in Humana Inc. in 2023. At the time of writing, the media sentiment of Humana Inc. is mostly positive. Investors should analyze the company’s financials and its competitive landscape before investing. Humana Inc. has a diversified revenue stream from both commercial and Medicare products.
Its balance sheet is strong, cash flow is healthy, and the company has continued to return value to shareholders through dividends and share repurchases. The company is also engaged in various initiatives to expand its reach and increase its customer base. Overall, Humana Inc. has solid fundamentals and appears to be an attractive option for investors.
Recent Posts